Rights Offer Opening

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com






FOR PUBLIC RELEASE

NZX Limited
Wellington

14 November 2024


Rua Bioscience Rights Offer Entitlement Opens

Rua Bioscience Limited (“RUA”) advises that the 3 for 4 pro-rata renounceable rights offer
(“Rights Offer”) to raise up to $3.1 million opens today at 2pm at www.shareoffer.co.nz/rua.

A copy of the Offer Document was lodged to the NZX on 6 November 2024.

The Rights Offer is available to eligible shareholders with a registered address in New
Zealand or Australia at 5.00pm NZST on Wednesday, 13 November 2024 (“Eligible
Shareholders”). Eligible Shareholders are being invited to subscribe for new shares at an
offer price of NZ$0.025c per new share.

Eligible Shareholders who wish to participate should apply and pay via
www.shareoffer.co.nz/rua by Tuesday, 26 November 2024. The Rights Offer is structured to
provide all Eligible Shareholders with a fair opportunity to participate while Eligible
Shareholders who take up their rights in full may also apply for additional shares at the same
price.

The Rights Offer is critical to supporting Rua’s ongoing business with the proceeds intended
to fund working capital to support sales growth and Rua’s immediate cash flow requirements.

Further information

The Offer Document and other important information about the Rights Offer is available on
the website established for the Entitlement Offer at www.shareoffer.co.nz/rua. Eligible
shareholders are encouraged to visit that website and read all the materials available or
referred to on it (including the Offer Document, investor presentation and market
announcement published by Rua Bioscience on 6
th
November (together, the “Offer Materials”)
before making a decision whether to apply online from 2pm, Thursday, 14 November 2024.

Additional information on Rua Bioscience can be found at
www.ruabio.com/capital-raise-november-2024


MARKET UPDATE

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com

Shareholders who have any questions about the Rights Offer are encouraged to seek
financial, investment or other professional advice from a qualified professional adviser.


ENDS  
 
The person who authorised this announcement:

Paul Naske
Chief Executive Officer
paul.naske@ruabio.com
+64 21 445154